Pharmaceuticals & Biotech Businesses for Sale
The compliance infrastructure, multi-year customer contracts, and switching costs built into regulated workflows are what make the best pharma and biotech businesses so hard for competitors to replicate.
3
New This Month
17
Active Listings
$4.3M
Median Asking Price
Browse listings
Featured Pharmaceuticals & Biotech Businesses
Showing 17 of 17 listings
In-Home Medication Management Pharmacy
Mushroom Wellness Products Business
Vitamins / Supplements Business
Chemical Supplier
Prescription Drug and Medical Diagnostic Wholesaler
Pain Management Medical Device Company
Biotechnology Research & Assay Development Laboratory
Digital Creative Agency for Biotech Industry
Online Health and Wellness Store
At-Home Allergy Treatment Business
Heath Information Publication Business
Wellness Products Retailer
Pharmacy
Research Diagnostics and Biotechnology Company
Medical Research Company
Life Sciences Technology Business
Lab Testing and Consulting for Food and Drug Industry
Search, filter, and find your perfect opportunity
Due diligence
What to Look For
Practical guidance from hundreds of real acquisition conversations.
Subscription Revenue Share
- Ask what percentage of revenue comes from subscriptions or annual contracts that renew automatically versus one-time project work.
- High recurring revenue changes the risk profile from day one and tends to support stronger financing terms.
- A business where 60 percent or more of revenue is contracted and predictable is a very different starting point than a project-driven one.
Customer Switching Costs
- In regulated industries, switching away from a compliance or traceability platform requires a full revalidation process that can cost hundreds of thousands of dollars and months of disruption.
- Ask how embedded the product is in each customer's actual operations, not just how long they've been a customer.
- Customers who would need months to revalidate before switching are the kind of retention story that holds through ownership changes.
Customer Tenure and Concentration
- Ask for a customer list with tenure dates, even if names are anonymized early in the process.
- Customers on the platform for five or more years without churning are a strong signal that the product genuinely delivers what it promises.
- Check whether any single customer represents more than 20 to 25 percent of revenue, and spend time understanding that relationship if they do.
Compliance Documentation
- Ask to see FDA records, validation documentation, and compliance certifications, and check that they're organized and current.
- Missing or disorganized compliance records can slow the process down and create questions that are hard to answer quickly.
- A seller with clean, well-maintained compliance files is signaling that the business has been run with real discipline.
Expansion Potential
- Some of the best businesses in this space have proven their platform in one vertical and have clear, untapped potential in adjacent ones like animal health, food safety, or medical devices.
- Ask where the product has already expanded and where it hasn't yet, which tells you a lot about the growth opportunity you'd be acquiring.
- A proven platform in one regulated market with a natural path into a second is a meaningful strategic advantage.
Valuation
What Should You Expect to Pay?
3x-6x
SDE
Founder-dependent with some recurring revenue
6x-12x
EBITDA
With team running independently and high recurring revenue from long-tenure customers
The spread is driven by how much revenue is truly recurring, how embedded the product is in customer operations, and whether the business can run without the founder's direct involvement.
What drives a premium
Majority of revenue from annual subscriptions that renew without active sales effort
Customers deeply embedded in the platform with high switching costs due to revalidation requirements
Multi-year customer retention with documented tenure history across the customer base
Compliance records including FDA documentation and validation certifications organized and current
SBA Loan Calculator
See what your monthly payments would look like at different deal sizes
Thinking About Selling?
Read our owner's guide to selling a pharmaceuticals & biotech business, with valuation tips, buyer expectations, and step-by-step advice.
FAQ
Pharmaceuticals & Biotech Business Acquisition
What should I look for when buying a pharmaceuticals or biotech business?
Start with the revenue model. Businesses where most revenue comes from subscriptions that renew automatically are fundamentally more predictable than those dependent on new customer acquisition. Then understand customer switching costs. In regulated industries, embedded compliance and traceability tools are very hard to replace, which keeps customers in place. Browse pharmaceuticals and biotech businesses for sale on Rejigg to see what's currently available.
How much does a pharmaceuticals or biotech business cost?
Most pharma and biotech businesses sell for 3 to 12 times annual profit, with the wide range reflecting the significant difference between founder-dependent services businesses and highly recurring software platforms with strong customer retention. Use the SBA loan calculator to model your financing options and required equity.
How do I evaluate a pharmaceuticals or biotech business before buying?
Ask for a breakdown of recurring versus non-recurring revenue. Get customer tenure data and understand the concentration of your top five customers. Review compliance documentation including FDA records and validation certificates. Understand whether any key technical or regulatory knowledge is concentrated in the founder, and ask how the team is structured to handle customer relationships independently.
What due diligence questions should I ask about a pharmaceuticals or biotech business?
Ask what percentage of revenue comes from subscriptions that renew without active sales effort. Find out how long each of the top customers has been active and whether any have contracted for multi-year terms. Ask to see FDA documentation and validation records. Understand the technical architecture and whether switching away from the platform requires revalidation. Ask about the founder's involvement in customer relationships and the transition plan.
Where can I find pharmaceuticals and biotech businesses for sale?
Rejigg connects buyers with owners of pharma software companies, biotech services businesses, compliance platforms, and other regulated life sciences companies. You can browse pharmaceuticals and biotech businesses for sale on Rejigg and connect with owners directly.
How does regulation affect the value of a pharma or biotech business?
Regulation is actually a positive factor when it comes to customer retention. Compliance and traceability requirements create steady demand for products and services that help manufacturers meet those requirements. Once a company is set up and validated on a system, switching to a competitor involves a costly revalidation process. That dynamic creates durable customer loyalty that buyers find genuinely valuable.
What if the founder is deeply involved in customer relationships?
Founder-dependent customer relationships are one of the most common risk factors in this space and worth understanding clearly. Ask whether the technical team and account managers have their own direct relationships with customers, and how long those have been in place. A thoughtful transition plan where the seller stays involved for a defined period can bridge this gap effectively, but you want to understand the landscape before you close.
